https://reurl.cc/4a88LV
路透社报导
Fosun-BioNTech COVID-19 vaccine completes China regulator review - media
SHANGHAI, July 15 (Reuters) - Chinese regulators have completed an expert
review of a COVID-19 mRNA vaccine developed by Germany's BioNTech (22UAy.DE)
and Fosun Pharma (600196.SS) and the shot is in the administration review
stage, Caixin reported, citing the Chinese company.
China hasn't approved any COVID-19 vaccine developed overseas but
greenlighted several domestic brands, administering 1.4 billion doses so far,
or two-fifths of the global total of 3.47 billion doses.
BioNTech Chief Executive Ugur Sahin said in April he expected its COVID-19
vaccine would win approval from the Chinese authorities "by June at the
latest."
BioNTech and Fosun did not immediately reply to Reuters' requests for comment.
The vaccine is on track to begin trial production in China at the end of
August, Caixin cited Fosun Pharma chairman Wu Yifang as saying at a
shareholders' meeting on Wednesday.
It said the vaccine would be used as a booster shot for people who have
received vaccines using inactivated viruses.
These are vaccines that use a coronavirus that cannot replicate in human
cells and include Sinovac's (SVA.O) COVID-19 shot.
简单来说就是中国政府对BNT疫苗已经通过专家审查，进入行政审查并预计作为那些打过
科兴、国药的人的第三针加强剂，然后八月底复星在中国开始试生产BNT疫苗
复星：反正你最后都还是要打BNT的，为什么不一开始就打BNT呢，ㄏㄏ
好险郭董跟GG已经完成签约了，不然再过几个月复星真的可能不卖台湾了....因为优先供给中国国内
只是这算是侧面说中国国产疫苗算是不成功吗?因为最后还是要打国外的疫苗XD